Explore the innovative concept of vibe coding and how it transforms drug discovery through natural language programming.

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leader in AI-powered solutions for drug discovery and development, has been honored with the “AI-based Drug Discovery Solution of the Year” award in the ...

The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...

Daphne Koller, founder and CEO of Insitro, has secured major partnerships with pharmaceutical giants like Eli Lilly and Bristol Myers Squibb to advance A.I.-powered drug discovery. Courtesy of Insitro ...

Eli Lilly and Nvidia are partnering to build what the companies call the pharmaceutical industry's "most powerful" supercomputer and so-called AI factory to help accelerate drug discovery and ...

How are we improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule? The drug development pipeline is a costly and ...

Regina Barzilay is a School of Engineering Distinguished Professor of AI & Health in the department of computer science and the AI faculty lead at MIT Jameel Clinic. She develops machine learning ...

Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, reports the publication of a manuscript in the journal Science, which ...

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, ...

New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...